BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7800155)

  • 1. Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal men.
    Steiger A; Benkert O; Holsboer F
    Neuropsychobiology; 1994; 30(2-3):101-5. PubMed ID: 7800155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of trimipramine on sleep EEG, penile tumescence and nocturnal hormonal secretion. A long-term study in 3 normal controls.
    Steiger A; Benkert O; Wöhrmann S; Steinseifer D; Holsboer F
    Neuropsychobiology; 1989; 21(2):71-5. PubMed ID: 2515468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of brofaremine (CGP 11 305A), a short-acting, reversible, and selective inhibitor of MAO-A on sleep, nocturnal penile tumescence and nocturnal hormonal secretion in three healthy volunteers.
    Steiger A; Holsboer F; Benkert O
    Psychopharmacology (Berl); 1987; 92(1):110-4. PubMed ID: 3110820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of moclobemide on the psychophysiology of sleep/wake cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide.
    Minot R; Luthringer R; Macher JP
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):181-9. PubMed ID: 8468440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of moclobemide on nocturnal sleep of depressed patients.
    Monti JM; Alterwain P; Monti D
    J Affect Disord; 1990 Nov; 20(3):201-8. PubMed ID: 2148341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients.
    Monti JM
    Br J Psychiatry Suppl; 1989 Oct; (6):61-5. PubMed ID: 2619974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls.
    von Bardeleben U; Steiger A; Gerken A; Holsboer F
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():1-5. PubMed ID: 2536765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
    Koulu M; Scheinin M; Kaarttinen A; Kallio J; Pyykkö K; Vuorinen J; Zimmer RH
    Br J Clin Pharmacol; 1989 Feb; 27(2):243-55. PubMed ID: 2469451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the young-adult synchrony between luteinizing hormone release and oscillations in follicle-stimulating hormone, prolactin, and nocturnal penile tumescence (NPT) in healthy older men.
    Veldhuis JD; Iranmanesh A; Mulligan T; Pincus SM
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3498-505. PubMed ID: 10522986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moclobemide effects on prolactin plasma levels in healthy individuals: the hormonal increase induced by a single dose is maintained during a 4-week period of drug intake.
    Juruena MF; Pires ML; Calil HM
    Int Clin Psychopharmacol; 1997 Nov; 12(6):317-21. PubMed ID: 9547133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.
    Sonntag A; Rothe B; Guldner J; Yassouridis A; Holsboer F; Steiger A
    Depression; 1996; 4(1):1-13. PubMed ID: 9160649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mianserin on human sleep.
    Maeda Y; Hayashi T; Furuta H; Kim Y; Morikawa K; Ishiguro N; Ueno K; Sano J; Yamaguchi N
    Neuropsychobiology; 1990-1991; 24(4):198-204. PubMed ID: 2135711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the reversible MAO-A inhibitor moclobemide increases prolactin secretion by a serotonergic mechanism in healthy male volunteers.
    Scheinin M; Koulu M; Karhuvaara S; Zimmer RH
    Life Sci; 1990; 47(16):1491-9. PubMed ID: 2250565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Burkard WP; Bonetti EP; Da Prada M; Martin JR; Polc P; Schaffner R; Scherschlicht R; Hefti F; Müller RK; Wyss PC
    J Pharmacol Exp Ther; 1989 Jan; 248(1):391-9. PubMed ID: 2913284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clomipramine on sleep EEG and nocturnal penile tumescence: a long-term study in a healthy man.
    Steiger A
    J Clin Psychopharmacol; 1988 Oct; 8(5):349-54. PubMed ID: 3183074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men.
    Murck H; Guldner J; Colla-Müller M; Frieboes RM; Schier T; Wiedemann K; Holsboer F; Steiger A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R905-11. PubMed ID: 8897980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between rapid eye movement sleep and testosterone secretion in normal men.
    Luboshitzky R; Herer P; Levi M; Shen-Orr Z; Lavie P
    J Androl; 1999; 20(6):731-7. PubMed ID: 10591612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men -- possible therapeutic implications.
    Murck H; Steiger A
    Psychopharmacology (Berl); 1998 Jun; 137(3):247-52. PubMed ID: 9683002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
    Nair NP; Ahmed SK; Kin NM
    J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of moclobemide on sexual performance and nocturnal erections in psychogenic erectile dysfunction.
    Mann K; Pankok J; Leissner J; Benkert O
    Psychopharmacology (Berl); 2001 Jun; 156(1):86-91. PubMed ID: 11465638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.